eLaws | eCases | United States Code | Federal Courts |
Home » 2003 Issues » 68 FR (09/18/2003) » 03-23779. Oral Dosage Form New Animal Drugs; Change of Sponsor

  03-23779. Oral Dosage Form New Animal Drugs; Change of Sponsor  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for two approved new animal drug applications (NADAs) from Teva Pharmaceuticals USA to Delmarva Laboratories, Inc.

    DATES:

    This rule is effective September 18, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: dnewkirk@cvm.fda.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Teva Pharmaceuticals USA, 650 Cathill Rd., Sellersville, PA 18960, has informed FDA that it has transferred ownership of, and all rights and interest in, the following two approved NADAs to Delmarva Laboratories, Inc., 1500 Huguenot Rd., suite 106, Midlothian, VA 23113:

    NADA No.Trade Name
    65-492ROBAMOX V (amoxicillin trihydrate) Tablets
    65-495ROBAMOX V (amoxicillin trihydrate)

    Accordingly, the agency is amending the regulations in 21 CFR 520.88b and 520.88f to reflect the transfer of ownership.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects in 21 CFR Part 520

    • Animal drugs
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows:

    End Amendment Part Start Part

    PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 520 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    2. Section 520.88b Amoxicillin trihydrate for oral suspension is amended in paragraph (c) by removing “Sponsor. See Nos. 000093 and 000856” and by adding in its place “Sponsors. See Nos. 000856 and 059079”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    3. Section 520.88f Amoxicillin trihydrate tablets is amended in paragraph (b) by removing “Sponsor. See Nos. 000093 and 000856” and by adding in its place “Sponsors. See Nos. 000856 and 059079”.

    End Amendment Part Start Signature

    Dated: August 28, 2003.

    Steven D. Vaughn,

    Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 03-23779 Filed 9-17-03; 8:45 am]

    BILLING CODE 4160-01-S

Visit the Official Version
Leave a Comment

Document Information

Effective Date:
9/18/2003
Published:
09/18/2003
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
03-23779
Dates:
This rule is effective September 18, 2003.
Pages:
54658-54658 (1 pages)
PDF File:
03-23779.pdf
CFR: (2)
21 CFR 520.88b
21 CFR 520.88f